Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer

We appreciate the critical review of our analysis of patient reported outcome measures (PROMs) in definitive chemoradiation for non-small cell lung cancer (NSCLC). In their editorial, Voong et al . thoughtfully discuss use of PROMs in locally advanced lung cancer. They highlight important limitations of our data, many of which are commonly encountered in studies of patient reported outcomes (PROs).